EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Efficacy and safety of middle meningeal artery embolisation for chronic subdural haematoma: a systematic review and meta-analysis of randomised controlled trials

Jolie Jin En Wong, Mohammed Jameel, Rocío Pérez, Nader Ameri, Zaid A Dajani, Nada Alfahad, Guido Firmani

Neurosurgical Review · 11.11.2026 · 49 (1)

DOI: 10.1007/s10143-026-04568-4 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Neurosurgical Review, online erschienen am 11.11.2026. Verfasst von Jolie Jin En Wong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical student, Cardiff University School of Medicine, Neuadd Meirionnydd, Cardiff, CF14 4YS, Wales, UK. WongJE1@cardiff.ac.uk. Hauptthemen laut MEDLINE: Hematoma, Subdural, Chronic, Embolization, Therapeutic, Meningeal Arteries. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic subdural haematoma (cSDH) frequently recurs following standard treatment. Middle meningeal artery embolisation (MMAE) may reduce recurrence by decreasing perfusion of the vascularised subdural membranes. This systematic review and meta-analysis evaluated the efficacy and safety of MMAE versus standard management. This PRISMA-compliant systematic review and meta-analysis (PROSPERO: CRD420261325584) searched PubMed, Ovid (MEDLINE and Embase), Web of Science, and the Cochrane Library from inception to 28 September 2026. Randomised controlled trials comparing MMAE-based treatment with standard management in adults with radiologically confirmed cSDH were included. Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using random-effects models. The primary outcome was study-defined treatment failure. Twelve randomised controlled trials ( n = 2,429; 1,202 MMAE; 1,227 control) were included in the primary analysis. Treatment failure occurred in 9.1% versus 18.3%, respectively. MMAE reduced treatment failure (RR 0.52, 95% CI 0.39–0.69), corresponding to an absolute risk reduction of approximately 8.8% and an NNT of approximately 12. In subgroup analyses, benefit was observed in both surgery-only comparator trials (RR 0.41, 95% CI 0.23–0.76) and mixed surgical/conservative comparator trials (RR 0.55, 95% CI 0.37–0.81), with no significant subgroup difference ( p = 0.317). MMAE also reduced reoperation/surgical rescue (RR 0.40, 95% CI 0.31–0.52). All-cause mortality (RR 0.72, 95% CI 0.37–1.43) and severe adverse events (RR 0.83, 95% CI 0.60–1.16) did not differ significantly between groups. Certainty was moderate for treatment failure and reoperation/surgical rescue and low for mortality and severe adverse events. MMAE-based treatment reduces treatment failure in cSDH, with no statistically significant difference in mortality or severe adverse events. Further well-powered randomised trials using standardised efficacy and safety outcomes are needed to define the optimal role of MMAE in cSDH management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematoma, Subdural, ChronicEmbolization, TherapeuticMeningeal ArteriesHumansRandomized Controlled Trials as TopicTreatment Outcome

Stichwörter der Autor:innen

Chronic subdural haematomaMeta-analysisMiddle meningeal artery embolisationRandomised controlled trialRecurrenceSystematic review

Autor:innen und Institutionen

  • Medical student, Cardiff University School of Medicine, Neuadd Meirionnydd, Cardiff, CF14 4YS, Wales, UK. WongJE1@cardiff.ac.uk.
  • East Lancashire Hospital Trust, Blackburn, England, UK.
  • Clinica Auna, Lima, Peru.
  • Clinica IV Ortoplastica, Instituto Ortopedico Rizzoli, Bologna, Italy.
  • College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Barnet Hospital, London, England, UK.

Zitieren

APA

Wong, J. J. E., Jameel, M., Pérez, R., Ameri, N., Dajani, Z. A., Alfahad, N., & Firmani, G. (2026). Efficacy and safety of middle meningeal artery embolisation for chronic subdural haematoma: a systematic review and meta-analysis of randomised controlled trials. Neurosurgical Review, 49(1). https://doi.org/10.1007/s10143-026-04568-4

Vancouver

Wong JJE, Jameel M, Pérez R, Ameri N, Dajani ZA, Alfahad N, et al. Efficacy and safety of middle meningeal artery embolisation for chronic subdural haematoma: a systematic review and meta-analysis of randomised controlled trials. Neurosurgical Review. 2026;49(1). doi:10.1007/s10143-026-04568-4

BibTeX
@article{Wong2026,
  author = {Wong, Jolie Jin En and Jameel, Mohammed and Pérez, Rocío and Ameri, Nader and Dajani, Zaid A and Alfahad, Nada and Firmani, Guido},
  title = {Efficacy and safety of middle meningeal artery embolisation for chronic subdural haematoma: a systematic review and meta-analysis of randomised controlled trials},
  journal = {Neurosurgical Review},
  year = {2026},
  volume = {49},
  number = {1},
  doi = {10.1007/s10143-026-04568-4}
}
Kostenlos starten →